Cancer Treatment in India — Surgery, Chemo, Proton Therapy & CAR-T Guide (2026)

Why International Patients Choose India for Cancer Treatment

India treats over 1.5 million new cancer cases annually and has built an oncology infrastructure that rivals any country in the world — at a fraction of the cost. Tata Memorial Hospital alone sees 70,000 new cancer patients every year, more than most Western cancer centers see in a decade.

For international patients, the value proposition is staggering: a complete cancer surgery in India costs $3,000–$8,000 versus $15,000–$60,000 in the US. A full chemotherapy course runs $3,600–$11,500 versus $30,000–$120,000. And India’s indigenous CAR-T cell therapy costs $45,000–$85,000 — roughly 10x cheaper than the $400,000–$500,000 price tag in the United States.

But cancer treatment is not a single procedure. It is a multi-modality, multi-month journey. The headline cost of “surgery” or “chemo” is just the beginning. This guide breaks down exactly what each modality costs, where to get it, and the hidden expenses that can multiply your bill 3–5x.

---

The Four Pillars of Cancer Treatment in India

Cancer treatment in India spans four major modalities. Most patients require a combination of two or more.

Modality	Cost in India	Cost in US	Cost in UK	Cost in UAE	Savings vs US
Cancer Surgery	$3,000–$8,000	$15,000–$60,000	$12,000–$45,000	$10,000–$25,000	75–87%
Chemotherapy (12 cycles)	$3,600–$11,500	$30,000–$120,000	$20,000–$80,000	$10,000–$40,000	85–90%
Proton Beam Therapy	$12,000–$36,000	$80,000–$150,000	$40,000–$80,000	Not available	76–85%
CAR-T Cell Therapy	$45,000–$85,000	$400,000–$500,000	$350,000–$450,000	Not available	83–89%

Critical caveat: Most cancer patients do not need just one modality. A breast cancer patient, for example, may undergo surgery ($4,000–$6,000) + 6 cycles of adjuvant chemotherapy ($1,800–$5,750) + 25 fractions of radiation ($2,000–$5,000) + 1 year of Herceptin ($11,520–$17,280). The total: $19,320–$34,030 in India versus $150,000–$300,000+ in the US. Post-surgery adjuvant therapy can stretch treatment duration to 3–6 months and multiply the initial surgery cost by 3–5x.

---

Modality 1: Cancer Surgery

Cancer surgery in India is the most cost-effective modality. Indian oncosurgeons perform tens of thousands of tumor resections, organ-sparing surgeries, and radical procedures annually.

Surgery Cost by Cancer Type

Cancer Type	Surgery	Cost in India	Cost in US	Hospital Stay
Breast Cancer	Mastectomy / lumpectomy	$2,500–$5,000	$15,000–$35,000	2–4 days
Colorectal Cancer	Colectomy (open/laparoscopic)	$3,500–$7,000	$20,000–$50,000	5–7 days
Lung Cancer	Lobectomy / VATS	$4,000–$8,000	$25,000–$60,000	5–10 days
Head & Neck Cancer	Radical excision + flap reconstruction	$3,000–$7,000	$20,000–$55,000	7–14 days
Liver Cancer	Partial hepatectomy	$5,000–$8,000	$30,000–$60,000	7–10 days
Prostate Cancer	Radical prostatectomy (robotic)	$4,500–$7,500	$20,000–$45,000	3–5 days
Brain Tumor	Craniotomy / CyberKnife	$5,000–$8,000	$30,000–$80,000	5–10 days
Stomach Cancer	Gastrectomy	$3,500–$6,500	$20,000–$50,000	7–10 days

Robotic Surgery Availability

India’s top cancer centers now use the da Vinci Xi robotic surgical system for prostate, colorectal, gynecologic, and head-and-neck cancers. Robotic surgery adds $1,000–$2,000 to the base cost but offers faster recovery, less blood loss, and shorter hospital stays. Apollo, Fortis, and Tata Memorial all offer robotic oncosurgery.

What’s Included in Surgery Cost

• Pre-operative imaging (CT/PET-CT/MRI): $200–$500
• Surgeon and anesthesiologist fees
• Operating room charges
• Hospital stay (private/semi-private room)
• Post-operative ICU monitoring (1–2 days if needed)
• Histopathology and biopsy reporting

What’s NOT Included

• Chemotherapy or radiation if recommended post-surgery
• Targeted therapy or immunotherapy drugs
• Prosthetics or implants (breast reconstruction adds $1,500–$3,000)
• Extended stay beyond standard discharge timeline

---

Modality 2: Chemotherapy

Chemotherapy is where India’s cost advantage is most dramatic. India is the world’s pharmacy — the country manufactures 60% of the world’s vaccines and is the largest producer of generic pharmaceuticals. Under India’s compulsory licensing framework, cancer drugs that cost thousands per dose in the US are available as bioequivalent generics at 80–90% lower prices.

Chemotherapy Cost Breakdown

Regimen	Cancer Type	Per Cycle (India)	6–12 Cycles (India)	Per Cycle (US)	6–12 Cycles (US)
FOLFOX	Colorectal	$300–$600	$3,600–$7,200	$3,000–$5,000	$36,000–$60,000
AC-T (Adriamycin + Taxol)	Breast	$250–$500	$2,000–$6,000	$2,500–$4,000	$20,000–$48,000
ABVD	Hodgkin Lymphoma	$200–$450	$2,400–$5,400	$2,000–$4,000	$24,000–$48,000
Cisplatin + Etoposide	Lung	$300–$550	$1,800–$6,600	$3,000–$5,000	$18,000–$60,000
R-CHOP	Non-Hodgkin Lymphoma	$400–$800	$2,400–$4,800	$4,000–$8,000	$24,000–$48,000
Gemcitabine + Carboplatin	Ovarian	$350–$600	$2,100–$7,200	$3,500–$6,000	$21,000–$72,000

Key Drug Price Comparisons

Drug	Indication	Per Dose (India)	Per Dose (US)	Savings
Trastuzumab (Herceptin biosimilar)	HER2+ Breast Cancer	$960–$1,440	$4,500+	68–79%
Imatinib (Gleevec generic)	CML	$200/month	$9,000+/month	98%
Bevacizumab (Avastin biosimilar)	Colorectal, Lung	$250–$400	$3,000–$5,000	88–92%
Pembrolizumab (Keytruda)	Multiple cancers	$1,800–$2,500	$10,000–$12,000	75–82%
Rituximab (biosimilar)	NHL, CLL	$300–$500	$3,500–$5,000	86–90%
Nivolumab (Opdivo)	Melanoma, Lung	$1,200–$2,000	$7,000–$10,000	71–83%

Why are Indian generics so cheap? India’s Patents Act allows compulsory licensing for essential medicines. Indian pharmaceutical companies like Cipla, Natco, Dr. Reddy’s, and Biocon produce biosimilar and generic versions of blockbuster cancer drugs. These generics must pass bioequivalence testing by the DCGI and are used by India’s top cancer hospitals including Tata Memorial. The WHO pre-qualifies many of these Indian generics for global use.

Targeted Therapy and Immunotherapy

Targeted therapy and checkpoint inhibitor immunotherapy are increasingly standard in cancer care. In India, these advanced drugs are available at significantly lower cost:

• Herceptin (trastuzumab) biosimilar: 17 cycles over 1 year costs approximately $16,320–$24,480 in India versus $76,500+ in the US
• Pembrolizumab (Keytruda): A 2-year course (35 cycles) costs approximately $63,000–$87,500 in India versus $350,000–$420,000 in the US
• Osimertinib (Tagrisso) for EGFR+ lung cancer: $1,500–$2,000/month in India versus $15,000+/month in the US

Hidden Chemotherapy Costs

Beyond the drug price, chemotherapy incurs additional expenses that international patients must budget for:

Item	Cost in India
Port-a-cath insertion	$400–$800
Anti-nausea medication (per cycle)	$20–$50
Growth factor injections (Neulasta biosimilar)	$50–$100 per injection
Blood transfusions (if needed)	$30–$60 per unit
Weekly blood work monitoring	$15–$30 per panel
Oncologist consultation (per visit)	$20–$50

---

Modality 3: Proton Beam Therapy

Proton beam therapy is the most precise form of radiation therapy available. Unlike conventional photon radiation, protons deposit their energy at a specific depth (the Bragg peak) and stop — delivering virtually zero exit dose to tissue beyond the tumor. This makes proton therapy ideal for cancers near critical structures: pediatric brain tumors, skull base tumors, spinal tumors, and head-and-neck cancers.

Where to Get Proton Therapy in India

Apollo Proton Cancer Centre, Chennai is currently South Asia’s only operational proton therapy facility. Key facts:

• Opened in 2019 with a pencil-beam scanning (PBS) system
• Sub-millimeter accuracy for tumor targeting
• Treated patients from 147 countries
• Full gantry rotation with image-guided treatment verification
• Dedicated international patient department with language support, visa assistance, and accommodation coordination

Tata Memorial Centre, Mumbai is building a government-funded proton therapy center. When operational, it will treat 60% of patients free of charge — consistent with Tata Memorial’s mission of subsidized cancer care for economically disadvantaged patients.

Proton Therapy Cost Breakdown

Component	Cost in India	Cost in US
Treatment planning (CT simulation, contouring)	$500–$1,000	$3,000–$5,000
Per-fraction delivery (25–35 fractions typical)	$350–$900	$2,500–$4,000
Full course (25 fractions)	$8,750–$22,500	$62,500–$100,000
Full course (35 fractions)	$12,250–$31,500	$87,500–$140,000
Weekly on-treatment oncologist review	Included	$500–$1,000/visit
Typical total	$12,000–$36,000	$80,000–$150,000

Best Candidates for Proton Therapy

Cancer Type	Why Proton Is Preferred	Standard Fractions
Pediatric brain tumors	Minimizes radiation to developing brain — reduces cognitive side effects	25–30
Skull base chordomas/chondrosarcomas	High dose needed near brainstem and optic nerves	35–39
Head and neck cancers	Preserves salivary glands, reduces dry mouth	30–35
Prostate cancer	Reduces rectal and bladder exposure	20–28
Liver cancer (HCC)	Spares surrounding liver tissue for patients with limited hepatic reserve	5–15
Spinal/paraspinal tumors	Protects spinal cord from radiation damage	25–30
Re-irradiation cases	Limits cumulative dose to previously irradiated tissues	Variable

Proton Therapy vs Conventional Radiation (IMRT)

Factor	Proton Beam	Conventional IMRT
Cost in India	$12,000–$36,000	$2,000–$5,000
Precision	Sub-millimeter (Bragg peak)	Millimeter-level
Exit dose	Near zero	Significant
Side effects	50–60% fewer acute side effects	Standard
Treatment duration	5–7 weeks (daily)	5–7 weeks (daily)
Availability in India	1 center (Chennai)	Widely available
Best for	Pediatric, skull base, re-irradiation	Most adult cancers

For most common adult cancers (breast, lung, cervical), conventional IMRT at $2,000–$5,000 is clinically equivalent to proton therapy and far more accessible. Proton therapy’s advantage is specific to cases where sparing surrounding tissue is critical.

---

Modality 4: CAR-T Cell Therapy

CAR-T (Chimeric Antigen Receptor T-cell) therapy is the most revolutionary — and most expensive — cancer treatment available globally. It involves extracting a patient’s own T-cells, genetically engineering them in a lab to recognize and attack cancer cells, then infusing them back into the patient.

In the US, a single CAR-T infusion costs $400,000–$500,000 for the drug alone. Total treatment cost including hospitalization, monitoring, and managing side effects exceeds $600,000–$1,000,000.

India has changed this equation entirely.

India’s Indigenous CAR-T: NexCAR19

NexCAR19, developed by ImmunoACT — a spin-off of the Indian Institute of Technology (IIT) Bombay and Tata Memorial Hospital — is India’s first indigenously developed CAR-T cell therapy. Key milestones:

• Developed through a collaboration between IIT Bombay engineering and Tata Memorial clinical oncology
• Approved by India’s CDSCO (Central Drugs Standard Control Organisation)
• 400+ patients treated as of early 2026
• Targets CD19 antigen on B-cell malignancies
• GST-exempt since January 2025, reducing the financial burden further
• Manufactured in India, eliminating the need to ship cells internationally

CAR-T Cost Comparison

Cost Component	India (NexCAR19)	US (Kymriah/Yescarta)
CAR-T product (manufacturing + infusion)	$30,000–$50,000	$373,000–$475,000
Hospitalization (2–4 weeks)	$5,000–$15,000	$50,000–$150,000
Cytokine release syndrome management	$3,000–$8,000	$20,000–$80,000
Follow-up monitoring (3 months)	$2,000–$5,000	$10,000–$30,000
Bridging chemotherapy (if needed)	$1,000–$3,000	$5,000–$15,000
Total	$45,000–$85,000	$460,000–$750,000

CAR-T Process Timeline in India

Phase	Duration	What Happens
Initial evaluation	3–5 days	PET-CT, bone marrow biopsy, cardiac assessment, infection screening
Leukapheresis (T-cell collection)	1 day	T-cells collected via apheresis machine
CAR-T manufacturing	14–21 days	Cells engineered and expanded in GMP facility
Lymphodepletion chemotherapy	3 days	Low-dose chemo to prepare immune system
CAR-T infusion	1 day	Single IV infusion
Monitoring for CRS/ICANS	14–21 days	Inpatient monitoring for cytokine release syndrome and neurotoxicity
Total in-country time	5–8 weeks	—

Who Is Eligible for CAR-T in India?

NexCAR19 is currently approved for:

• Relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL)
• Relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
• Other aggressive B-cell non-Hodgkin lymphomas

Patients must have failed at least two prior lines of therapy. Clinical trials are expanding indications to multiple myeloma and other cancers.

---

Total Treatment Cost: Multi-Modality Scenarios

Most cancer patients require combined treatment. Here is what realistic, end-to-end treatment costs look like in India versus the US:

Cancer Scenario	Treatment Plan	Total Cost (India)	Total Cost (US)
Early-stage breast cancer	Surgery + 6 chemo cycles + 25 radiation fractions + 1 year Herceptin	$19,000–$34,000	$150,000–$300,000
Stage III colorectal cancer	Surgery + 12 FOLFOX cycles + targeted therapy	$10,000–$22,000	$90,000–$200,000
Pediatric brain tumor	Proton therapy (30 fractions) + chemotherapy	$16,000–$42,000	$100,000–$200,000
Relapsed DLBCL	CAR-T cell therapy	$45,000–$85,000	$460,000–$750,000
Locally advanced lung cancer	Concurrent chemoradiation + immunotherapy (1 year)	$22,000–$45,000	$200,000–$400,000
Head and neck cancer	Surgery + proton therapy + chemo	$18,000–$48,000	$120,000–$280,000

Important: These estimates include direct medical costs only. International patients must also budget for:

• Return flights ($500–$2,000 per trip, multiple trips may be needed)
• Accommodation near hospital ($30–$80/night for 1–6 months)
• Visa fees and medical visa documentation ($25–$100)
• Local transport, meals, and caregiver expenses ($500–$1,500/month)
• Travel insurance with medical evacuation coverage

---

Top Cancer Hospitals in India

Tata Memorial Hospital, Mumbai

• India’s oldest and largest dedicated cancer center (established 1941)
• 70,000 new cancer patients per year
• 60% of patients treated free of cost — subsidized by the Tata Trusts
• Departments covering all cancer types with dedicated surgical, medical, and radiation oncology divisions
• Active CAR-T cell therapy program with ImmunoACT (NexCAR19)
• Government-funded proton therapy center under construction
• NABL-accredited laboratories

Rajiv Gandhi Cancer Institute & Research Centre, Delhi

• 300-bed dedicated cancer hospital
• Robotic surgery with da Vinci Xi system
• Bone marrow transplant unit (over 500 transplants performed)
• Dedicated international patient wing with translators
• PET-CT, CyberKnife, and TrueBeam linear accelerator

Apollo Cancer Centre, Chennai

• Part of Apollo Hospitals Group — Asia’s largest healthcare network
• Home to Apollo Proton Cancer Centre — South Asia’s only proton facility
• Patients from 147 countries treated
• Tumor board reviews for every case (multidisciplinary team)
• Dedicated international patient services: airport pickup, visa letter, accommodation, interpreter

HCG Cancer Centre, Bangalore

• India’s largest dedicated cancer care network (25+ centers)
• Pioneers of precision oncology in India
• Molecular tumor board with genomic profiling
• Advanced radiation: TomoTherapy, CyberKnife, TrueBeam
• Clinical trials for novel immunotherapy agents

AIIMS, Delhi

• India’s premier government medical institution
• Some of India’s most experienced oncologists and oncosurgeons
• Extremely low cost (government-subsidized)
• Long wait times for international patients — better suited for second opinions
• Active clinical research and trials

---

How to Plan Your Cancer Treatment Trip to India

Step 1: Get a Remote Consultation (Week 1)

Most top hospitals offer teleconsultation with oncologists before you travel. Share your medical records, pathology slides, and imaging via the hospital’s international patient portal. Expect a preliminary treatment plan and cost estimate within 3–5 business days. Consultation fee: $30–$100.

Step 2: Obtain a Medical Visa

India offers a dedicated Medical Visa (M-Visa) valid for up to 1 year, with provisions for a Medical Attendant Visa for one companion. Processing time: 5–10 business days. Required documents: hospital invitation letter, medical records, passport, proof of funds.

Step 3: Arrive and Complete Diagnostic Workup (Week 1–2)

Even if you bring scans from home, most Indian hospitals will repeat key diagnostics to ensure accuracy. A full cancer workup in India costs:

Test	Cost in India
PET-CT (whole body)	$250–$500
MRI (targeted)	$100–$200
CT scan (contrast)	$60–$120
Biopsy + histopathology	$100–$300
Tumor marker panel	$30–$80
Genomic profiling (Foundation One equivalent)	$800–$1,500
Bone marrow biopsy	$100–$200

Step 4: Tumor Board Review

At JCI/NABH-accredited hospitals, your case will be presented to a multidisciplinary tumor board — typically comprising a surgical oncologist, medical oncologist, radiation oncologist, pathologist, and radiologist. This ensures your treatment plan reflects global best practices. There is no additional charge for tumor board review at most hospitals.

Step 5: Begin Treatment

Treatment timelines vary dramatically by modality (see individual sections above). Coordinate with the hospital’s international patient coordinator for scheduling, accommodation near the hospital, and caregiver logistics.

---

What International Patients Should Know

Language and Communication

English is the working language at all top cancer hospitals in India. Medical reports, consent forms, and discharge summaries are in English. Arabic, French, Russian, and Bangla interpreters are available at Apollo, Fortis, and Max hospitals for patients from the Middle East, Africa, and Bangladesh.

Second Opinions

India’s oncology ecosystem makes it easy and affordable to get second opinions. A second-opinion consultation costs $30–$80. Pathology slide review by a second center costs $50–$150. For international patients investing in multi-modality cancer treatment, getting a second opinion from a different top-tier hospital is strongly recommended.

Insurance and Payment

Some international insurance providers (Bupa International, Cigna Global, Allianz Care) cover treatment at JCI-accredited Indian hospitals. Check your policy for pre-authorization requirements. Most hospitals require 50–75% advance payment before starting treatment. Payment plans are available at select private hospitals for treatment courses exceeding $20,000.

Medical Records and Continuity of Care

All top hospitals provide comprehensive digital discharge summaries, pathology reports, imaging on CD/USB, and a detailed treatment protocol for your oncologist at home. Many hospitals offer post-discharge teleconsultation follow-ups at no charge for 30–60 days.

---

The Adjuvant Therapy Trap: Why Cancer Costs Multiply

The single most important financial planning insight for cancer patients: surgery is often just the beginning. Post-surgery adjuvant therapy — chemotherapy, radiation, targeted therapy, immunotherapy — can stretch treatment to 3–6 months and multiply the initial surgery cost by 3–5x.

Example: A patient flies to India for breast cancer surgery ($4,000). The pathology reveals HER2-positive, node-positive disease. The tumor board recommends:

• 6 cycles of AC-T chemotherapy: $1,500–$3,000
• 25 fractions of radiation: $2,000–$3,500
• 17 cycles of Herceptin over 1 year: $16,320–$24,480

Total: $23,820–$34,980 — roughly 6–9x the surgery cost alone.

Even at this total, the patient saves $100,000–$250,000 compared to the same treatment in the US. But budgeting only for surgery is a common and costly mistake.

---

Key Takeaways

1. Cancer surgery is the most affordable modality: $3,000–$8,000 for most cancers, with 75–87% savings over the US.
2. Chemotherapy offers the highest percentage savings due to India’s generic drug manufacturing — 80–90% cheaper than branded drugs, with WHO-prequalified bioequivalence.
3. Proton beam therapy is available at Apollo Chennai ($12,000–$36,000) with Tata Memorial’s government center coming online. It is best for pediatric, skull base, and re-irradiation cases.
4. CAR-T cell therapy via India’s indigenous NexCAR19 costs $45,000–$85,000 — a 10x reduction from US pricing — and has treated 400+ patients.
5. Budget for the full treatment arc, not just surgery. Multi-modality treatment commonly costs $19,000–$85,000 in India, still saving 70–90% over equivalent care in the US and UK.
6. Tata Memorial Hospital is the world’s highest-volume cancer center, treating 70,000 new patients annually, with 60% receiving free care — a testament to India’s commitment to accessible oncology.